4 - NeueHealth, Inc. (0001671284) (Issuer)
4 - NeueHealth, Inc. (0001671284) (Issuer)
4 - NeueHealth, Inc. (0001671284) (Issuer)
4 - NeueHealth, Inc. (0001671284) (Issuer)
4 - NeueHealth, Inc. (0001671284) (Issuer)
4 - NeueHealth, Inc. (0001671284) (Issuer)
4 - NeueHealth, Inc. (0001671284) (Issuer)
4 - NeueHealth, Inc. (0001671284) (Issuer)
4 - NeueHealth, Inc. (0001671284) (Issuer)
4 - NeueHealth, Inc. (0001671284) (Issuer)
Delivered strong first quarter performance as care model continues to resonate with consumers, providers, and payors across the healthcare industry Drove positive Adjusted EBITDA for the fifth consecutive quarter, providing a strong foundation for continued success in 2025 and beyond Served approximately 709,000 consumers, an increase of 51% over the first quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its first quarter ended March 31, 2025. "We are starting 2025 in a very strong position, generating substantial growth in the number of consumers we serve and delivering another
NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report first quarter financial results before the financial markets open on Thursday, May 8, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests participant
Delivered strongest financial performance to date in 2024, resulting from continued success of value-driven, consumer-centric care model Drove positive Adjusted EBITDA for the fourth consecutive quarter in 2024, establishing the foundation for continued strong performance in 2025 and beyond Generated significant growth to start 2025, serving 717,000 consumers, an increase of 48% compared to 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2024. "In 2024, we delivered our strongest financial performance to date, demonstrating the power of our
NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report fourth quarter and full year 2024 financial results before the financial markets open on Thursday, March 20, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The com
NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today announced that it has entered into a definitive merger agreement pursuant to which the Company will be acquired by an affiliate of New Enterprise Associates ("NEA") at an enterprise value of approximately $1.3 billion. Upon completion of the transaction, NeueHealth will become a privately held company with the flexibility and resources to continue advancing its value-driven, consumer-centric care model. Under the terms of the merger agreement, holders of NeueHealth common stock (other than shares that will be rolled over and certain excluded shares) will receive $7.33 per share in cash
Delivered strongest financial performance to date in Q3 ‘24, resulting from continued positive momentum in NeueCare and NeueSolutions business segments Drove positive Adjusted EBITDA for the third consecutive quarter in 2024; reaffirming Adjusted EBITDA guidance for the full year† Well-positioned to build on success and capitalize on strategic growth opportunities in 2025 and beyond NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its third quarter ended September 30, 2024. "We are pleased to report another quarter of strong financial performance as we continue to build on the positive momentum we
NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today announced that Centrum Health, one of the Company's value-driven clinic brands, became a wholly owned subsidiary through the Company's acquisition of the remaining 25% equity interest of the business that it did not already own. This action simplifies NeueHealth's corporate structure, streamlining operations to support its ongoing focus on advancing its value-driven, consumer-centric care model. "We are pleased to announce this transaction as it further positions NeueHealth to take the lead in creating a more coordinated, seamless healthcare experience for all consumers," said Mike Mika
NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Thursday, November 7, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests partic
Drove solid Q2 ‘24 results with continued focus on advancing value-driven model and delivering high-quality, consumer-centric care to all populations across the ACA Marketplace, Medicare, and Medicaid Delivered positive Adjusted EBITDA for the second consecutive quarter in 2024; reaffirming Adjusted EBITDA guidance for the full year Positioned for continued strong performance this year and beyond, expecting to reach high end of guidance range for consumers served by year-end NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its second quarter ended June 30, 2024. "We continued to build momentum
NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report Second Quarter financial results before the financial markets open on Wednesday, August 7, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests part
10-Q - NeueHealth, Inc. (0001671284) (Filer)
8-K - NeueHealth, Inc. (0001671284) (Filer)
8-K - NeueHealth, Inc. (0001671284) (Filer)
DEF 14A - NeueHealth, Inc. (0001671284) (Filer)
SC 13E3/A - NeueHealth, Inc. (0001671284) (Subject)
DEFM14A - NeueHealth, Inc. (0001671284) (Filer)
SC 13E3/A - NeueHealth, Inc. (0001671284) (Subject)
PRER14A - NeueHealth, Inc. (0001671284) (Filer)
10-K - NeueHealth, Inc. (0001671284) (Filer)
8-K - NeueHealth, Inc. (0001671284) (Filer)
SC 13D/A - NeueHealth, Inc. (0001671284) (Subject)
Delivered strong first quarter performance as care model continues to resonate with consumers, providers, and payors across the healthcare industry Drove positive Adjusted EBITDA for the fifth consecutive quarter, providing a strong foundation for continued success in 2025 and beyond Served approximately 709,000 consumers, an increase of 51% over the first quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its first quarter ended March 31, 2025. "We are starting 2025 in a very strong position, generating substantial growth in the number of consumers we serve and delivering another
NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report first quarter financial results before the financial markets open on Thursday, May 8, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests participant
Delivered strongest financial performance to date in 2024, resulting from continued success of value-driven, consumer-centric care model Drove positive Adjusted EBITDA for the fourth consecutive quarter in 2024, establishing the foundation for continued strong performance in 2025 and beyond Generated significant growth to start 2025, serving 717,000 consumers, an increase of 48% compared to 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2024. "In 2024, we delivered our strongest financial performance to date, demonstrating the power of our
NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report fourth quarter and full year 2024 financial results before the financial markets open on Thursday, March 20, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The com
Delivered strongest financial performance to date in Q3 ‘24, resulting from continued positive momentum in NeueCare and NeueSolutions business segments Drove positive Adjusted EBITDA for the third consecutive quarter in 2024; reaffirming Adjusted EBITDA guidance for the full year† Well-positioned to build on success and capitalize on strategic growth opportunities in 2025 and beyond NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its third quarter ended September 30, 2024. "We are pleased to report another quarter of strong financial performance as we continue to build on the positive momentum we
NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today announced that Centrum Health, one of the Company's value-driven clinic brands, became a wholly owned subsidiary through the Company's acquisition of the remaining 25% equity interest of the business that it did not already own. This action simplifies NeueHealth's corporate structure, streamlining operations to support its ongoing focus on advancing its value-driven, consumer-centric care model. "We are pleased to announce this transaction as it further positions NeueHealth to take the lead in creating a more coordinated, seamless healthcare experience for all consumers," said Mike Mika
NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Thursday, November 7, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests partic
Drove solid Q2 ‘24 results with continued focus on advancing value-driven model and delivering high-quality, consumer-centric care to all populations across the ACA Marketplace, Medicare, and Medicaid Delivered positive Adjusted EBITDA for the second consecutive quarter in 2024; reaffirming Adjusted EBITDA guidance for the full year Positioned for continued strong performance this year and beyond, expecting to reach high end of guidance range for consumers served by year-end NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its second quarter ended June 30, 2024. "We continued to build momentum
NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report Second Quarter financial results before the financial markets open on Wednesday, August 7, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests part
Drove strong Q1 ‘24 results, focused on delivering coordinated, consumer-centric care to all populations through strong provider and payor partnerships and proactive consumer engagement Delivered Revenue of $245.1 million, Net Income from Continuing Operations of $5.7 million, Adjusted EBITDA of $2.5 million in Q1 ‘24, laying a solid foundation for continued profitable growth in 2024 NeueCare and NeueSolutions segments positioned for continued strong performance this year; maintaining expectation for 2024 Adjusted EBITDA of between $15 and $25 million† NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial result